Protagenic Therapeutics, Inc. Enters into Amendment No. 1 to At Market Issuance Sales Agreement
On January 9, 2025, Protagenic Therapeutics, Inc. announced that it has entered into Amendment No. 1 to the At Market Issuance Sales Agreement with B. Riley Securities, Inc. The Sales Agreement, dated July 2, 2021, enables the company to offer and sell shares of its common stock through the Agent, with an aggregate offering price […]
More Stories
Fifth Third Bancorp (NASDAQ:FITB) Receives $46.24 Average Target Price from Brokerages
Fifth Third Bancorp (NASDAQ:FITB – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the eighteen...
Great Southern Copper (LON:GSCU) Stock Price Up 13% – Should You Buy?
Great Southern Copper PLC (LON:GSCU – Get Free Report) shares rose 13% during trading on Friday . The stock traded...
Analysts Set Enphase Energy, Inc. (NASDAQ:ENPH) Price Target at $73.95
Enphase Energy, Inc. (NASDAQ:ENPH – Get Free Report) has received an average rating of “Hold” from the thirty-two ratings firms...
Essex Property Trust (ESS) Projected to Post Quarterly Earnings on Tuesday
Essex Property Trust (NYSE:ESS – Get Free Report) is projected to announce its Q1 2025 earnings results after the market...
LGI Homes (LGIH) Projected to Post Quarterly Earnings on Tuesday
LGI Homes (NASDAQ:LGIH – Get Free Report) is expected to be posting its Q1 2025 quarterly earnings results before the...
Capital Clean Energy Carriers (CCEC) Projected to Post Quarterly Earnings on Tuesday
Capital Clean Energy Carriers (NASDAQ:CCEC – Get Free Report) will likely be posting its Q1 2025 quarterly earnings results before...